HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies - Wikidata - awgldk - TriplyDB

HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies

HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies

http://www.wikidata.org/entity/Q34561257

about

Chronic HCV infection: epidemiological and clinical relevance Review and management of drug interactions with boceprevir and telaprevir Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis HIV infection, aging, and immune function: implications for cancer risk and prevention Hepatitis C.Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients Disparities and risks of sexually transmissible infections among men who have sex with men in China: a meta-analysis and data synthesis.PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus.Hepatitis C virus infection in the human immunodeficiency virus infected patient.Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6.Crosstalk between HIV and hepatitis C virus during co-infection Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis.Variation in both IL28B and KIR2DS3 genes influence pegylated interferon and ribavirin hepatitis C treatment outcome in HIV-1 co-infection.Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia IL28B gene polymorphisms in mono- and HIV-coinfected chronic hepatitis C patients.Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.Renal disease in HIV-infected individuals The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action.Effect of hepatitis C virus infection on the outcomes of in vitro fertilization HIV/hepatitis C coinfection natural history and disease progression.Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome Epidemiological implications of HIV-hepatitis C co-infection in South and Southeast Asia Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received Increasing incidence of recent hepatitis C virus infection among persons seeking voluntary counselling and testing for HIV and sexually transmitted infections in Taiwan Human immunodeficiency virus and viral hepatitis among high-risk groups: Understanding the knowledge gap in the Middle East and North Africa Region Alterations of the NK cell pool in HIV/HCV co-infection Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.Low-level HIV infection of hepatocytes.Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania.Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease The HCV care continuum among people who use drugs: protocol for a systematic review and meta-analysis HCV treatment in children and young adults with HIV/HCV co-infection in Europe.

P2860

Q21261812-998685E6-B39B-48B4-A2D7-A58B0C5237CD Q24628716-38B2FCD7-237A-45F4-AAE0-ABD3EABCECE1 Q26798469-4394F572-9CA0-42CF-86C0-5CF86F59DA99 Q26991791-EF46E6B9-E390-47D7-9BD6-2340D2A941B1 Q27004165-3F117638-5156-4B37-AE3C-13BE678C9591 Q28084654-5AAE4156-0190-4F6E-9A52-8F1F1BE27656 Q28540864-98271B95-3A6A-4549-9C3A-CE669A74AA57 Q28550423-F42ED90E-5A32-4E37-814A-15DCF6D1302D Q30768795-A74E009E-0CD8-48EA-8195-A3820356E3AC Q34074331-802B909B-25BB-4AD7-8952-2A5670DD15C9 Q34168504-AC82A411-A03E-46B4-A6EB-04CBFA58C051 Q34199743-6EBAF956-9544-4F5C-B043-D0E0FA47DF9E Q34218972-8A0E1020-FB34-4CDF-9079-B66EF66DA394 Q34329530-F9419595-2B8D-4A43-BAF1-1FE6F5F9A579 Q34359120-596A9E50-8F00-43EF-8957-7A9B43D54852 Q34427088-BFD39BF1-1B7B-4968-9C5C-E657A29BD270 Q34473823-4376427B-EB5E-4B83-BF6B-0F68998903B6 Q34511438-43730CDD-AB69-4BF0-807F-CACE5FA78F1B Q34796111-4D5BDAEC-9C1E-48E9-8DA6-0D3698B5A132 Q35095416-B4B15D1B-3FFF-4648-896D-F2C5F6D8993B Q35146008-3484600A-F508-42F4-994A-C423E0974F7A Q35235877-BD2870F5-569D-4310-A871-F3F26DAB6707 Q35698442-34A1DFDE-A1F2-4552-8B94-71436720211D Q35725969-CA930830-129F-4C94-B5D9-D99081B553F0 Q35742761-F0BBCC0E-F433-4C38-997F-700F9C52A0FA Q35791809-780CD74C-2CEF-428F-B0F2-9A468E22DBD3 Q35801431-431796CC-A43A-4005-A7DD-199F4D0D35C3 Q35916020-7C1A0303-25B7-416F-83F6-373C045621E6 Q35980818-EAC68159-1BC5-4EDE-8599-93B8D20CD4B9 Q36130220-CE719A35-60BF-49EB-87AB-12430C10A6FA Q36163340-2C62C44F-0848-4445-A0DB-1E39EDC25EFA Q36254138-EA615111-2786-412D-8339-8967008D9737 Q36336081-C445ECB0-FD00-4FFF-81E8-2CD9DAF48DDF Q36661756-74C40DDD-63CD-49CB-A428-9BEA99D1DA1F Q36715589-E380CC5B-566A-42F5-B4CA-0807595E3FF4 Q36730274-A426A33C-615E-40DD-A70A-ED4E134111BE Q36783269-968778D7-3B0C-41D2-A2D1-29660FC7E0E9 Q37046208-58CABFBB-4FCA-4331-9A6C-0AD75A6F6EBF Q37084628-68AF1F21-A52D-4BC0-9EC8-DD25E8039E0D Q37098372-13C9C93D-9D5F-478B-B68F-81170DF15FBA

P2860

HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies

http://www.wikidata.org/entity/Q34561257

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@ast

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@en

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@nl

type

label

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@ast

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@en

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@nl

prefLabel

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@ast

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@en

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@nl

P1433

Q34561257-C000CC42-88BB-46DF-BE05-9E4AC3FEBD4A

P1476

Q34561257-B4CE9A34-10AC-4794-816A-6779BB55F976

P2093

Q34561257-1084352C-FEA4-4CFD-B820-BFBCE07BA3BF

Q34561257-E0C3BE23-29AF-4FC4-8C79-BCBE7B909F7A

P2860

Q34561257-00425E2E-BA69-4002-8954-55660E905463

Q34561257-01E26502-333A-4C69-B188-5027AB45604D

Q34561257-027D5EFC-F718-4DCA-833E-D8C696444C89

Q34561257-042789C3-9836-4838-979C-6615FBF55DD0

Q34561257-04AE9153-F2FF-47DE-BCE0-1FCC25B781D9

Q34561257-0505FB8B-C6AB-4BF4-B1E8-633016CE8D60

Q34561257-05D96F98-EA6D-4BE8-948D-1C473DB22A3E

Q34561257-07A6755C-90E1-4A78-8B42-C3039B7AC3A0

Q34561257-0A064FB1-B804-42F8-9278-CE6BF68F1E1C

Q34561257-0A33838C-2564-4EDC-A0E4-DFD2AA448354

P2888

Q34561257-ECEF4A65-48EF-48ED-99DD-A97CD900FD21

P304

Q34561257-E6A93F58-6876-4747-87B2-AFAC6339374E

P31

Q34561257-06AEF0EF-FE10-4D65-9070-BB6BC76AC9E8

Q34561257-BEF20C9A-B6FA-4295-9368-56D5B723894F

P356

Q34561257-0D2104F2-9842-4632-8238-1B01C5E3B82E

P433

Q34561257-B8AF44AD-425D-4B65-97AB-B5B5F954BCE9

P478

Q34561257-E06810E4-B89D-4B75-9FF1-F045A1B92709

P577

Q34561257-CFD3447A-3ECD-4009-9180-DD97ED8BB575

P5875

Q34561257-B733BE9C-A6C9-41B8-9279-D11741A578C2

P698

Q34561257-B936F2A9-2B4E-4C74-90EA-99280E7EFB1C

P921

Q34561257-07801CA0-A3F3-477F-8A5A-CE9946F17119

Q34561257-29CDE06D-F2DE-43AF-9C91-0B5DE333741B

Q34561257-6AC12981-8A29-4E54-AB1D-378843ED4283

Q34561257-DFBAAB73-0709-4713-B408-A117C376E662

Q34561257-E7987E17-A5F6-40F2-A5E5-188ACD6E5D79

P932

Q34561257-C6CB49C7-A949-4B4F-A90A-AC00A9CD07F4

P356

S11904-010-0071-3

P1433

Current HIV/AIDS reports

P1476

HIV/HCV co-infection: pathogen ...... d new therapeutic technologies

@en

P2093

Andrea Kovacs

http://www.w3.org/2001/XMLSchema#string

Eva A Operskalski

http://www.w3.org/2001/XMLSchema#string

P2860

Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus

Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization

Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase

Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes

Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients

The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis

High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin trea

Factors Associated with Prevalent Hepatitis C Infection Among HIV-Infected Women with No Reported History of Injection Drug Use: The Women's Interagency HIV Study (WIHS)

Hepatitis C Virus (HCV) Quasispecies Complexity and Selection in HCV/HIV‐Coinfected Subjects Treated with Interferon‐Based Regimens

P2888

s11904-010-0071-3

P304

12-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11904-010-0071-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49743389

http://www.w3.org/2001/XMLSchema#string

P698

21221855

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

P932

3035774

http://www.w3.org/2001/XMLSchema#string